SCHEMBL23747356

SCHEMBL23747356

COc1ccc(CNC(=O)Nc2ccc(CC(=O)N3CC(OC)C3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.60
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
HDAC1 Q13547 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
ALDH1A1 P00352 2/20 0.54
HPGD P15428 1/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
POLB P06746 2/20 0.53
KDM4E B2RXH2 1/20 0.51
ROCK2 O75116 1/20 0.51
MAPT P10636 1/20 0.51
NAMPT P43490 3/20 0.50
SAE1 Q9UBE0 1/20 0.48
UBA2 Q9UBT2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26100239 0.90 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26100472 0.89 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26098918 0.89 RAB9A (0.56) SMN1; SMN2NPC1RAB9AALDH1A1MEN1
SCHEMBL23747343 0.88 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747476 0.88 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747578 0.88 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26099623 0.87 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26099137 0.87 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747816 0.86 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26549142 0.86 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885NPC1 463/4885RAB9A 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.